Eucalyptus is a global telehealth provider building a safe, effective and accessible future for medicine.
Eucalyptus has raised $33.2M in total funding. The most recent round was Series C. The last funding was announced in April 2023.
Eucalyptus's investors include Bond, Blackbird Ventures, Airtree Ventures, NewView Capital, OneVentures.
Eucalyptus is headquartered in Sydney, Australia.
Eucalyptus is a global telehealth provider building a safe, effective and accessible future for medicine.
Eucalyptus is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Eucalyptus — Funding & Investors." VCBacked, April 27, 2023, https://www.vcbacked.co/company/eucalyptus. Accessed July 19, 2026.
VCBacked. (2023). Eucalyptus — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/eucalyptus
{{cite web |title=Eucalyptus — Funding & Investors |url=https://www.vcbacked.co/company/eucalyptus |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated